MoKi Analytics

MoKi Analytics GmbH is a start-up from Charité – University Medicine Berlin. The company was established in October 2017 by Dr. Judith Kikhney, biologist, and Prof. Dr. med. Annette Moter, specialized physician for microbiology and infectious diseases.

MoKi Analytics offers innovative products and services for the detection of microorganisms and biofilms by molecular biological methods, like FISH and PCR, sequencing and microbiome analysis. MoKi Analytics also offers standardized efficacy testing of antimicrobial products or devices.

Quality Management

Our goal is to provide our services correctly and rapidly to our senders and patients. If there are any discrepancies, questions or worries, please do not hesitate to contact us immediately.

You are welcome to address your concerns by telephone (+49 (0)30 80405950), by email (info@moki-analytics.com) or by mail (MoKi Analytics GmbH, Marienplatz 9, 12207 Berlin, Germany).

We will take care of your concern immediately and will inform you within five working days about the result. We will do everything in our power to find a satisfactory solution.

Please note, that complaints have no influence on the cooperation with the respective sender or patient. We use them as an opportunity to identify possibilities for improvement and to optimize our work.


Lifeform Biofilm

Biofilms are organized microbial communities of bacteria and/or fungi. The biofilm offers advantages for the microorganisms, such as nutrition, recalcitrance against antibiotics, and protection from the host immune system.

Knowledge about biofilms is crucial for the development of effective prevention measures and therapeutic decision-making.

Routine methods of microbiology such as culturing of pathogens or molecular amplification techniques may identify the microbial species, but they are unable to detect the lifeform biofilm.